grant

Developing a Chemically-Controlled RAS Toolset

Organization UNIVERSITY OF WASHINGTONLocation SEATTLE, UNITED STATESPosted 1 Sept 2024Deadline 31 Aug 2027
NIHUS FederalResearch GrantFY2025AddressAffectApoptosisApoptosis PathwayAutomobile DrivingBehaviorBindingC-terminalCancersCell Communication and SignalingCell FunctionCell PhysiologyCell ProcessCell SignalingCell membraneCellular FunctionCellular PhysiologyCellular ProcessChemicalsChimeraChimera organismComplexCytoplasmic MembraneDNA mutationDevelopmentDiseaseDisorderDoseEGF ReceptorEGFRERBB ProteinEnvironmentEnzyme GeneEnzymesEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor KinaseEpidermal Growth Factor Receptor Protein-Tyrosine KinaseEpidermal Growth Factor-Urogastrone ReceptorsExhibitsFutureGTPGTP BindingGTP PhosphohydrolasesGTP boundGTPasesGenetic ChangeGenetic defectGenetic mutationGoalsGuanosine TriphosphateGuanosine Triphosphate PhosphohydrolasesGuanosinetriphosphatasesHER1HumanIntegral Membrane ProteinIntracellular Communication and SignalingIntrinsic Membrane ProteinKineticsMalignant NeoplasmsMalignant TumorMeasuresMediatingMembraneMethodsModern ManMolecularMolecular InteractionMutationNaturePTK ReceptorsPhosphorylationPhysiologyPlasma MembranePlayPositionPositioning AttributeProcessProgrammed Cell DeathProliferatingProtein EngineeringProtein PhosphorylationProteinsRAS driven cancerRAS driven malignancyReceptor ProteinReceptor Protein-Tyrosine KinasesReceptor Tyrosine Kinase GeneRegulationResearchRoleScaffolding ProteinSignal TransductionSignal Transduction SystemsSignalingSignaling Factor Proto-OncogeneSignaling Pathway GeneSignaling ProteinSpecificitySubcellular ProcessSystemT-Cell DevelopmentT-Cell OntogenyT-Lymphocyte DevelopmentTGF-alpha ReceptorTM DomainTailTransforming Growth Factor alpha ReceptorTransmembrane DomainTransmembrane ProteinTransmembrane Protein GeneTransmembrane Receptor Protein Tyrosine KinaseTransmembrane RegionTyrosine Kinase Linked ReceptorsTyrosine Kinase ReceptorsUrogastrone Receptorbehavior influencebehavioral influencebiological signal transductionc-erbB-1c-erbB-1 Proteinchemical geneticschemoproteomicschimerasdevelopmentaldrivingerbB-1erbB-1 Proto-Oncogene ProteinerbBlextracellulargenetic protein engineeringgenome mutationguanosinetriphosphataseinsightmalignancymembrane activitymembrane structuremigrationmutantneoplasm/cancernovelplasmalemmaprotein designprotein oligomerproto-oncogene protein c-erbB-1receptorreceptor-mediated signalingrecruitsmall moleculesocial rolespatial and temporalspatial temporalspatiotemporalsynthetic biologytargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttool
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Abstract
RAS GTPase operates as a molecular switch toggling between GDP-bound (inactive) and GTP-bound forms

(active), and orchestrates dynamic cellular processes such as proliferation, migration, survival, and T-cell

development.1,2 Despite its binary nature, RAS exhibits sophisticated and dynamic signaling behavior influenced

by cellular context and subcellular localization. The lack of a precise understanding of the roles of spatiotemporal

compartmentalization in RAS hinders our understanding of fundamental signaling mechanisms and limits our

ability to develop targeted therapies for RAS-driven cancers. To address this, we will leverage a chemical genetic

tool called Chemically-Inducible Activator of RAS (CIAR) that allows the rapid and dose-dependent activation of

wild-type RAS with bio-orthogonal small molecules.8-10 Aim 1 describes efforts to use transmembrane-tethered

versions of NS3a-CIAR to dissect the impact of differential membrane localization on wild-type RAS activation

and downstream signaling. This Aim also describes the development of chemical tools for quantitatively

measuring the transmembrane localization of proteins and using a novel tool for probing RAS-GTP in its native

cellular context. Aim 2 aims to investigate the role of oligomerization of signaling proteins at membranes. An

engineered protein toolkit will be used to control the oligomeric state and study its impact on Ras-mediated

signaling. Finally, Aim 3 explores efforts to dissect how the intracellular signaling environment affects the kinetics

of magnitude of RAS activation and downstream signaling. This Aim also explores the development of a number

of chemical genetic tools for enabling intracellular protein display at membranes. Overall, the studies described

herein will offer new and important mechanistic insight into RAS signaling.

Grant Number: 5F31GM155953-02
NIH Institute/Center: NIH

Principal Investigator: Fernando Banales Mejia

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →